Growth Metrics

Welsis (WLSS) Debt to Equity (2021 - 2024)

Welsis' quarterly Debt to Equity came in at -$0.72 in Q2 2024, down 111.52% year-on-year from $6.24 in Q3 2023, and up 31.21% quarter-over-quarter from -$1.05 in Q1 2024.

Welsis has reported Debt to Equity for 4 years, with the latest figure at -$0.72 in Q2 2024.

  • For the quarter ending Q2 2024, Debt to Equity fell 111.52% year-over-year to -$0.72; the trailing twelve-month figure through Jun 2024 stood at -$0.72 (down 111.52% YoY), and the FY2023 full-year result was -$0.34, up 34.81% from the prior year.
  • Debt to Equity for Q2 2024 stood at -$0.72, up from -$1.05 in the prior quarter.
  • The five-year high for Debt to Equity was -$0.3 in Q4 2023, with the low at -$1.05 in Q1 2024.
  • Average Debt to Equity over 4 years is -$0.53, with a median of -$0.5 recorded in 2022.
  • Year-over-year, Debt to Equity soared 34.81% in 2023 and sank 197.91% in 2024.
  • Tracing WLSS's Debt to Equity over 4 years: stood at -$0.71 in 2021, then soared by 34.16% to -$0.46 in 2022, then soared by 34.38% to -$0.3 in 2023, then sank by 136.04% to -$0.72 in 2024.
  • The last three Debt to Equity figures came in at -$0.72 (Q2 2024), -$1.05 (Q1 2024), and -$0.3 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 1.26
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.46
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.37
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Welsis - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 -0.72
Mar 31, 2024 -1.05
Dec 31, 2023 -0.30
Sep 30, 2023 -0.34
Jun 30, 2023 -0.34
Mar 31, 2023 -0.35
Dec 31, 2022 -0.46
Sep 30, 2022 -0.52
Jun 30, 2022 -0.50
Mar 31, 2022 -0.53
Sep 30, 2021 -0.71